This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Medical; Abortion, Fetus

Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation

Sponsored by Gynuity Health Projects

About this trial

Last updated 12 years ago

Study ID

1002

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
All
Female
Female

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 13 years ago

What is this trial about?

The purpose of this study is to determine the efficacy and acceptability of a regimen of 200 mg mifepristone (Zacafemyl), followed 24-48 hours later by 800 mcg of buccal misoprostol.

What are the participation requirements?

Yes

Inclusion Criteria

- Women of reproductive age

- Gestational age less than or equal to 70 days LMP

- Willing and capable of accepting and participating

- Eligible for medical abortion according to the clinic's evaluation

- Willing to undergo a surgical intervention to complete the abortion if necessary

- Willing to provide an address and/or telephone number for follow up

- Have easy, straightforward access to a telephone and emergency transport

No

Exclusion Criteria

- Gestational age is greater than 70 days LMP

- Suspicion or diagnosis of ectopic pregnancy or undiagnosed adnexal mass

- Use of IUD (note: the woman will be eligible when she removes the IUD)

- Chronic renal failure

- Current long term treatment with corticosteroids

- Allergy to mifepristone, misoprostol, or other prostaglandin

- Coagulopathies or current treatment with anti-coagulants

- Hereditary porphyrias